Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) EBITDA (2016 - 2026)

Exponent filings provide 17 years of EBITDA readings, the most recent being -$59.7 million for Q1 2026.

  • On a quarterly basis, EBITDA fell 319.11% to -$59.7 million in Q1 2026 year-over-year; TTM through Jan 2026 was $30.9 million, a 74.13% decrease, with the full-year FY2026 number at $30.9 million, down 74.13% from a year prior.
  • EBITDA hit -$59.7 million in Q1 2026 for Exponent, down from $29.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $45.3 million in Q3 2022 to a low of -$91.0 million in Q4 2022.
  • Median EBITDA over the past 5 years was $29.5 million (2023), compared with a mean of $18.1 million.
  • Biggest five-year swings in EBITDA: tumbled 417.7% in 2022 and later soared 120.2% in 2023.
  • Exponent's EBITDA stood at -$91.0 million in 2022, then surged by 120.2% to $18.4 million in 2023, then soared by 40.52% to $25.8 million in 2024, then grew by 12.35% to $29.0 million in 2025, then tumbled by 305.64% to -$59.7 million in 2026.
  • The last three reported values for EBITDA were -$59.7 million (Q1 2026), $29.0 million (Q4 2025), and $17.2 million (Q3 2025) per Business Quant data.